頁籤選單縮合
題 名 | Dexmedetomidine versus Midazolam as Intranasal Premedication for Intravenous Deep Sedation in Pediatric Dental Treatment |
---|---|
作 者 | Cheng, Tong; Liu, Yun; Li, Bing-hua; Wu, Xiao-ran; Xia, Bin; Yang, Xu-dong; | 書刊名 | Journal of Dental Sciences |
卷 期 | 19:1 2024.01[民113.01] |
頁 次 | 頁285-291 |
分類號 | 416.991 |
關鍵詞 | Children; Deep intravenous sedation; Dental treatment; Dexmedetomidine; Premedication; |
語 文 | 英文(English) |
DOI | 10.1016/j.jds.2023.04.009 |
英文摘要 | Background/purpose Optimal sedation management for pediatric dental treatment demands special focus as it's tubeless and shares a same oral space. The study was to evaluate dexmedetomidine compared to midazolam for intranasal premedication in pediatric dental treatment under intravenous deep sedation. Materials and methods A hundred children aged 3–7 years scheduled for elective dental treatment under intravenous deep sedation anesthesia were enrolled, of whom 50 children (Group D) were intranasally premedicated with 2.0 μg/kg dexmedetomidine and the remaining 50 children (Group M) received traditional 0.2 mg/kg midazolam. Acceptance rate of venipuncture was regarded as the primary endpoint. Results The acceptance rate of venipuncture in Group D and Group M were 76% versus 52%, respectively (P = 0.021). More children in Group M complained about bitter/sour taste than Group D (62% vs. 8%, P < 0.001). Intraoperatively, children in Group M were found to have more choking cough than Group D (30% vs. 9%, P = 0.003), and patients in Group M required more suction (18 [36%] in Group M vs. 4 [8%] in Group D, P = 0.001). There were no significant differences between the groups in the incidences of temporal hypoxemia (SpO2 ≤ 90%), however, two children in Group M experienced hypoxemia over 10 s. Conclusion Compared to the 0.2 mg/kg midazolam, children premedicated with 2.0 μg/kg intranasal dexmedetomidine showed superior venipuncture acceptance, had less intraoperative choking cough and required fewer suction. It seems to be a good alternative to midazolam as premedication for deep sedation in pediatric dental treatment. |
本系統中英文摘要資訊取自各篇刊載內容。